New Products

Cat. No.	Product Name	Target	Research Area	Added	Chemical Structure

HY-145636	Vobramitamab duocarmazine	Antibody-Drug Conjugates (ADCs)	Cancer	2025-12
HY-P99741	Mirzotamab clezutoclax	Antibody-Drug Conjugates (ADCs); Bcl-2 Family; CD276/B7-H3	Cancer	2025-12
HY-179219S	RTx-303	DNA/RNA Synthesis	Cancer	2025-12
HY-177564	Delpacibart zotadirsen	Antibody-Oligonucleotide Conjugates (AOCs); Transferrin Receptor	Inflammation/Immunology	2025-12
HY-N16848	Foeniculoside II	Others	Others	2025-12
HY-179152	Apoptosis inducer 54	Apoptosis; Topoisomerase	Cancer	2025-12
HY-167238	RS-30199	5-HT Receptor	Neurological Disease	2025-12
HY-P11265	YQGN-7	GnRH Receptor; Fluorescent Dye	Cancer	2025-12
HY-179298	Anticancer agent 283	Drug Derivative	Cancer	2025-12
HY-W674149	ABI-274	Microtubule/Tubulin	Cancer	2025-12
HY-D2977	AF-1	Fluorescent Dye; Autophagy; Fungal	Infection	2025-12
HY-176938A	iAfaPhos1	EGFR	Cancer	2025-12
HY-N6020R	(-)-Butin (Standard)	Reference Standards; Drug Isomer	Cardiovascular Disease; Inflammation/Immunology	2025-12
HY-19463	F-15845 hydrobromide	Sodium Channel	Cardiovascular Disease	2025-12
HY-D2951	BG-Kaede chromophore	Fluorescent Dye	Others	2025-12
HY-D3014	Labelling Kits Centrifugation-Based Rapid Desalting Column (5KD)	Others	Others	2025-12
HY-108982	UK 55444	Calcium Channel	Cardiovascular Disease	2025-12
HY-19165	CI-996	Angiotensin Receptor	Cardiovascular Disease	2025-12
HY-176950	Crizotinib-amide-PEG2-NH2	Anaplastic lymphoma kinase (ALK); c-Met/HGFR; ROS Kinase; Target Protein Ligand-Linker Conjugates	Cancer	2025-12
HY-14433A	(S)-PF-462991	LPL Receptor	Inflammation/Immunology	2025-12

Name
Email *

	Sorry, but the email address you supplied was invalid.